Tenet Healthcare (NYSE:THC - Get Free Report) issued an update on its FY 2025 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of 15.550-16.210 for the period, compared to the consensus estimate of 12.819. The company issued revenue guidance of $21.0 billion-$21.3 billion, compared to the consensus revenue estimate of $20.9 billion.
Tenet Healthcare Price Performance
NYSE:THC traded down $9.59 on Thursday, hitting $148.72. The company had a trading volume of 1,740,876 shares, compared to its average volume of 1,596,786. The stock has a market capitalization of $13.81 billion, a price-to-earnings ratio of 9.52, a PEG ratio of 0.96 and a beta of 1.64. The company has a current ratio of 1.71, a quick ratio of 1.70 and a debt-to-equity ratio of 2.39. The firm has a 50 day moving average of $168.78 and a two-hundred day moving average of $144.78. Tenet Healthcare has a 52 week low of $109.82 and a 52 week high of $185.25.
Tenet Healthcare (NYSE:THC - Get Free Report) last issued its quarterly earnings data on Tuesday, July 22nd. The company reported $4.02 EPS for the quarter, beating the consensus estimate of $2.84 by $1.18. The business had revenue of $5.27 billion during the quarter, compared to the consensus estimate of $5.16 billion. Tenet Healthcare had a net margin of 7.17% and a return on equity of 24.69%. The firm's revenue was up 3.2% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $2.31 EPS. On average, research analysts anticipate that Tenet Healthcare will post 12.24 earnings per share for the current year.
Wall Street Analysts Forecast Growth
Several research firms have recently issued reports on THC. Raymond James Financial reaffirmed an "outperform" rating and set a $200.00 price target (up previously from $185.00) on shares of Tenet Healthcare in a research note on Wednesday. Morgan Stanley upped their price target on Tenet Healthcare from $175.00 to $210.00 and gave the company an "overweight" rating in a research report on Monday, June 9th. UBS Group upped their price target on Tenet Healthcare from $230.00 to $238.00 and gave the company a "buy" rating in a research report on Wednesday. Guggenheim upped their price target on Tenet Healthcare from $180.00 to $188.00 and gave the company a "buy" rating in a research report on Wednesday. Finally, Truist Financial set a $205.00 price target on Tenet Healthcare and gave the company a "buy" rating in a research report on Wednesday, July 16th. Four research analysts have rated the stock with a hold rating, fifteen have issued a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat.com, Tenet Healthcare presently has a consensus rating of "Moderate Buy" and a consensus price target of $187.12.
View Our Latest Analysis on Tenet Healthcare
Insiders Place Their Bets
In other Tenet Healthcare news, Director Richard W. Fisher sold 836 shares of the firm's stock in a transaction on Thursday, June 5th. The shares were sold at an average price of $173.16, for a total value of $144,761.76. Following the completion of the sale, the director directly owned 11,292 shares in the company, valued at approximately $1,955,322.72. This trade represents a 6.89% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director J Robert Kerrey sold 1,222 shares of the firm's stock in a transaction on Tuesday, May 27th. The stock was sold at an average price of $164.96, for a total transaction of $201,581.12. Following the completion of the sale, the director owned 22,377 shares of the company's stock, valued at $3,691,309.92. The trade was a 5.18% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 54,121 shares of company stock valued at $8,846,305. 0.81% of the stock is currently owned by corporate insiders.
Institutional Investors Weigh In On Tenet Healthcare
A hedge fund recently raised its stake in Tenet Healthcare stock. Jones Financial Companies Lllp grew its holdings in shares of Tenet Healthcare Corporation (NYSE:THC - Free Report) by 299.1% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,700 shares of the company's stock after buying an additional 1,274 shares during the quarter. Jones Financial Companies Lllp's holdings in Tenet Healthcare were worth $229,000 at the end of the most recent reporting period. 95.44% of the stock is owned by institutional investors and hedge funds.
About Tenet Healthcare
(
Get Free Report)
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.
Further Reading
Before you consider Tenet Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tenet Healthcare wasn't on the list.
While Tenet Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
